Navigation Links
First study to investigate the human genome in multiple sclerosis
Date:9/3/2013

SeattleSep. 4, 2013

The National Institutes of Health (NIH) awarded Benaroya Research Institute at Virginia Mason (BRI) a $1.9 million grant to find marks in the human genome which can explain why some white blood cells cause damage to the spinal cord and brain in multiple sclerosis (MS). This is the first study to look for molecular changes in the genome of specific immune cells responsible for the devastation caused by MS. The broad-based study will determine the function of these cells, how they are generated and how they can be regulated in system models of MS and in humans.

"We want to understand the factors that make these cells target the spinal cord and brain to cause disease," says Estelle Bettelli, PhD, BRI Assistant Member and co-principal investigator of the study. Dr. Bettelli and other scientists have identified different types of T cells which they believe are potent inducers of MS and other autoimmune diseases. She has also developed system models to study different forms of multiple sclerosis.

"With Dr. Bettelli's research advances and with the new technological innovations in genome research, we can look at specific marks present in the genome of these cells and understand how they are generated and how they can be controlled," says co-principal investigator Steven Ziegler, PhD, Director of the BRI Immunology Research Program. Dr. Ziegler has used whole genome studies to investigate these cell types in healthy individuals. "We can then see how the genomic marks affect the cells in model systems of MS and how they operate in humans cells with and without the disease. We can also see how these cells behave once the patient receives treatment and if various treatments make the cells act differently."

"It is important to know how and when these cells are formed in the body to determine how to inhibit their harmful function," says Dr. Bettelli. "It is becoming clear that MS is not a unique disease entity but can present itself in different clinical forms and variants. Several factors, including the cell types involved, are believed to dictate the clinical progression of MS. The understanding of how and which cell populations of the immune system participate in the autoimmune attack is very important for determining current treatments and designing new therapeutics tailored to the different forms of MS. We hope to find ways to significantly inhibit these dangerous cells with new targeted medicines with fewer side effects.

"This work highlights a key mechanism for understanding and modifying the immune cells that cause autoimmune diseases like MS," says BRI Director Gerald Nepom, MD, PhD. "It is an exciting example of the power of merging new genomic technologies with state-of-the-art immunology research to address a major clinical need."


'/>"/>

Contact: Kay Branz
kbranz@benaroyaresearch.org
206-342-6903
Immune Tolerance Network
Source:Eurekalert

Related biology news :

1. First estimate of total viruses in mammals
2. 23andMe conducts the first genetic study of non-syndromic striae distensae (stretch marks)
3. First update in a century in testing drugs for elemental impurities
4. BluStor Introduces the Worlds First Platform to Protect the Full Stream of Mobile Security: Device, User, And Data
5. Elsevier launches first video journal in gastrointestinal endoscopy
6. Mount Sinai researchers develop first successful laboratory model for studying hepatitis C
7. Nice organisms finish first: Why cooperators always win in the long run
8. First human tests of new biosensor that warns when athletes are about to hit the wall
9. U of M researchers unveil nations first porcine virus rapid detection test
10. A first in front line immunity research
11. First global atlas of marine plankton reveals remarkable underwater world
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2017)... Calif. , March 6, 2017 ... and sales technology, today announced Predictive Sales Coach ... for infusing actionable sales intelligence into Salesforce. This ... automatically enable their sales organizations with deep knowledge ... that allow for intelligent engagement. Predictive Sales Coach ...
(Date:3/2/2017)... , March 2, 2017 Who risk to ... Download the full report: https://www.reportbuyer.com/product/4313699/ ... FINGERPRINT SENSOR FIELD? Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:2/28/2017)... --  Acuant , a leading provider of data capture ... new and core technologies building upon the acquisition of ... desktop Acuant FRM TM facial recognition and match ... manual review of identity documents by accredited professionals. ... most accurate capture software to streamline workflows by securely ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... , March 29, 2017 The Global Microfluidic ... report is a specialized and comprehensive study on the existing state ... America , Europe and ... Middle East and Africa . ... Browse 172 Tables and ...
(Date:3/28/2017)... ... March 28, 2017 , ... NetDimensions announced ... processes and enhance training plan management for consistent implementation of standards and regulatory ... the SHL Group to help improve and streamline their training and employee development ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Franz Inc ... product, AllegroGraph , has been named a ‘Champion’ by Bloor Research in its ... highest ranked product in its class, and, thanks to Gruff, it was rated as ...
(Date:3/28/2017)... ... March 28, 2017 , ... Ecovia Renewables, ... Innovation Research (SBIR) grant from the National Science Foundation (NSF). Under the ... develop a suite of BioGel™ biopolymer materials for hygiene applications, particularly for use ...
Breaking Biology Technology: